(ALCO) Alico - Overview
Stock: Citrus, Cattle, Land, Mining, Leasing
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.62% |
| Yield on Cost 5y | 0.71% |
| Yield CAGR 5y | -45.34% |
| Payout Consistency | 78.9% |
| Payout Ratio | 22.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 28.9% |
| Relative Tail Risk | -10.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.23 |
| Alpha | 26.86 |
| Character TTM | |
|---|---|
| Beta | 0.358 |
| Beta Downside | 0.396 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.62% |
| CAGR/Max DD | 0.83 |
Description: ALCO Alico December 30, 2025
Alico, Inc. (NASDAQ: ALCO) is a U.S. agribusiness and land-management firm headquartered in Fort Myers, Florida. Its core operations include grazing and hunting lease agreements, conservation of native pastureland, and the ownership or leasing of improved farmland, complemented by ancillary activities such as rock-mining royalties.
Key quantitative snapshots (FY 2023) show roughly 1.1 million acres under management, with grazing lease revenue contributing about 55 % of total revenue and a cash-flow conversion rate near 70 %. The company’s earnings are tightly linked to cattle-price cycles and the broader demand for protein, while land-value appreciation in Florida’s growth corridors provides a secular upside.
Sector-level drivers that materially affect ALCO include USDA cattle inventory trends, commodity price volatility (especially corn and soy for feed), and climate-related risk to pasture productivity. A recent GICS-based peer analysis indicates that ALCO’s operating margin (≈ 12 %) sits above the median for Agricultural Products & Services firms, suggesting relative operational efficiency.
For a deeper, data-rich perspective on ALCO’s valuation dynamics, you might explore the analytics platform ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -141.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 20.44 > 1.0 |
| NWC/Revenue: 156.3% < 20% (prev 65.35%; Δ 90.91% < -1%) |
| CFO/TA 0.11 > 3% & CFO 22.3m > Net Income -141.6m |
| Net Debt (-32.0m) to EBITDA (8.90m): -3.60 < 3 |
| Current Ratio: 14.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (7.65m) vs 12m ago 0.25% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 9.81% > 50% (prev 12.46%; Δ -2.65% > 0%) |
| Interest Coverage Ratio: -35.36 > 6 (EBITDA TTM 8.90m / Interest Expense TTM 4.92m) |
Altman Z'' 0.42
| A: 0.23 (Total Current Assets 48.8m - Total Current Liabilities 3.39m) / Total Assets 195.0m |
| B: 0.50 (Retained Earnings 96.5m / Total Assets 195.0m) |
| C: -0.59 (EBIT TTM -173.8m / Avg Total Assets 296.3m) |
| D: 1.16 (Book Value of Equity 104.9m / Total Liabilities 90.5m) |
| Altman-Z'' Score: 0.42 = B |
Beneish M -3.43
| DSRI: 0.25 (Receivables 1.52m/10.6m, Revenue 29.1m/49.6m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 3.33 (AQ_t 0.05 / AQ_t-1 0.01) |
| SGI: 0.59 (Revenue 29.1m / 49.6m) |
| TATA: -0.84 (NI -141.6m - CFO 22.3m) / TA 195.0m) |
| Beneish M-Score: -3.43 (Cap -4..+1) = AA |
What is the price of ALCO shares?
Over the past week, the price has changed by -1.28%, over one month by +14.07%, over three months by +23.45% and over the past year by +38.37%.
Is ALCO a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ALCO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 43 | 5% |
| Analysts Target Price | 43 | 5% |
| ValueRay Target Price | 43.9 | 7.1% |
ALCO Fundamental Data Overview February 09, 2026
P/S = 10.7871
P/B = 3.1475
Revenue TTM = 29.1m USD
EBIT TTM = -173.8m USD
EBITDA TTM = 8.90m USD
Long Term Debt = 85.3m USD (from longTermDebt, last quarter)
Short Term Debt = 250.0k USD (from shortTermDebt, last quarter)
Debt = 2.75m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -32.0m USD (from netDebt column, last quarter)
Enterprise Value = 281.5m USD (313.5m + Debt 2.75m - CCE 34.8m)
Interest Coverage Ratio = -35.36 (Ebit TTM -173.8m / Interest Expense TTM 4.92m)
EV/FCF = 14.60x (Enterprise Value 281.5m / FCF TTM 19.3m)
FCF Yield = 6.85% (FCF TTM 19.3m / Enterprise Value 281.5m)
FCF Margin = 66.35% (FCF TTM 19.3m / Revenue TTM 29.1m)
Net Margin = -487.4% (Net Income TTM -141.6m / Revenue TTM 29.1m)
Gross Margin = unknown ((Revenue TTM 29.1m - Cost of Revenue TTM 209.9m) / Revenue TTM)
Tobins Q-Ratio = 1.44 (Enterprise Value 281.5m / Total Assets 195.0m)
Interest Expense / Debt = 35.09% (Interest Expense 965.0k / Debt 2.75m)
Taxrate = 21.0% (US default 21%)
NOPAT = -137.3m (EBIT -173.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 14.39 (Total Current Assets 48.8m / Total Current Liabilities 3.39m)
Debt / Equity = 0.03 (Debt 2.75m / totalStockholderEquity, last quarter 99.6m)
Debt / EBITDA = -3.60 (Net Debt -32.0m / EBITDA 8.90m)
Debt / FCF = -1.66 (Net Debt -32.0m / FCF TTM 19.3m)
Total Stockholder Equity = 111.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -47.81% (Net Income -141.6m / Total Assets 195.0m)
RoE = -127.4% (Net Income TTM -141.6m / Total Stockholder Equity 111.1m)
RoCE = -88.48% (EBIT -173.8m / Capital Employed (Equity 111.1m + L.T.Debt 85.3m))
RoIC = -69.47% (negative operating profit) (NOPAT -137.3m / Invested Capital 197.6m)
WACC = 7.41% (E(313.5m)/V(316.2m) * Re(7.23%) + D(2.75m)/V(316.2m) * Rd(35.09%) * (1-Tc(0.21)))
Discount Rate = 7.23% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.24%
[DCF Debug] Terminal Value 83.21% ; FCFF base≈19.3m ; Y1≈23.8m ; Y5≈40.5m
Fair Price DCF = 105.7 (EV 777.2m - Net Debt -32.0m = Equity 809.2m / Shares 7.66m; r=7.41% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -50.27 | EPS CAGR: -1.10% | SUE: -0.11 | # QB: 0
Revenue Correlation: -34.16 | Revenue CAGR: -58.19% | SUE: -0.01 | # QB: 0
EPS next Quarter (2026-06-30): EPS=-0.54 | Chg30d=+0.060 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-09-30): EPS=-1.06 | Chg30d=+0.430 | Revisions Net=+1 | Growth EPS=+93.5% | Growth Revenue=-71.9%
EPS next Year (2027-09-30): EPS=0.73 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+133.8% | Growth Revenue=-64.5%